These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37580752)

  • 1. Biopharma innovation trends during COVID-19 and beyond: an evidence from global partnerships and fundraising activities, 2011-2022.
    Yu TH; Mei YY; Tseng YJ
    Global Health; 2023 Aug; 19(1):57. PubMed ID: 37580752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving toward a common goal via cross-sector collaboration: lessons learned from SARS to COVID-19 in Singapore.
    Kim S; Goh Y; Kang JHB
    Global Health; 2022 Sep; 18(1):82. PubMed ID: 36131348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public-Private-People Partnerships (4P) for Improving the Response to COVID-19 in Iran.
    Seddighi H; Seddighi S; Salmani I; Sharifi Sedeh M
    Disaster Med Public Health Prep; 2021 Feb; 15(1):e44-e49. PubMed ID: 32576337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic.
    Eren Vural I; Herder M; Doll A; Graham JE
    Int J Health Policy Manag; 2023; 12():6936. PubMed ID: 37579382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investor initiatives program: Public-private partnerships to expedite commercialization for NCI-funded small business entrepreneurs.
    Connors B; Lou XJ; Subedee A; Zhang K; Weingarten M; Narayanan D
    Clin Transl Sci; 2021 Nov; 14(6):2124-2131. PubMed ID: 34387931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The strategic case for establishing public-private partnerships in cancer care.
    Holden DJ; Reiter K; O'Brien D; Dalton K
    Health Res Policy Syst; 2015 Oct; 13():44. PubMed ID: 26462913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceived roles, benefits and barriers of virtual global health partnership initiatives: a cross-sectional exploratory study.
    Umphrey L; Paasi G; Windsor W; Abongo G; Evert J; Haq H; Keating EM; Lam SK; McHenry MS; Ndila C; Nwobu C; Rule A; Tam RP; Olson D; Olupot-Olupot P
    Glob Health Res Policy; 2022 Apr; 7(1):11. PubMed ID: 35478077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The COVID-19 Innovation System.
    Sampat BN; Shadlen KC
    Health Aff (Millwood); 2021 Mar; 40(3):400-409. PubMed ID: 33539184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steering the Private Sector in COVID-19 Diagnostic Test Kit Development in South Korea.
    Lee S
    Front Public Health; 2020; 8():563525. PubMed ID: 33282810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public welfare crowdfunding decision-making of environmental nonprofit organizations based on social responsibility.
    Tang Z; Zhang X
    Environ Sci Pollut Res Int; 2023 Sep; 30(44):99992-100005. PubMed ID: 37624492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling technology innovation: how science, engineering, and industry methods can combine to generate beneficial socioeconomic impacts.
    Stone VI; Lane JP
    Implement Sci; 2012 May; 7():44. PubMed ID: 22591638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balancing the benefits and risks of public-private partnerships to address the global double burden of malnutrition.
    Kraak VI; Harrigan PB; Lawrence M; Harrison PJ; Jackson MA; Swinburn B
    Public Health Nutr; 2012 Mar; 15(3):503-17. PubMed ID: 22014282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026.
    Global Burden of Disease 2021 Health Financing Collaborator Network
    Lancet Glob Health; 2023 Mar; 11(3):e385-e413. PubMed ID: 36706770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to Achieve Transparency in Public-Private Partnerships Engaged in Hunger and Malnutrition Reduction.
    Eggersdorfer M; Bird JK
    World Rev Nutr Diet; 2016; 115():224-32. PubMed ID: 27198563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Food use in middle and high school fundraising: does policy support healthful practice? Results from a survey of Minnesota school principals.
    Kubik MY; Lytle LA; Farbakhsh K; Moe S; Samuelson A
    J Am Diet Assoc; 2009 Jul; 109(7):1215-9. PubMed ID: 19559138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The informal governance of public-private partnerships in UK obesity policy: Collaborating on calorie reduction or reducing effectiveness?
    Ralston R
    Soc Sci Med; 2021 Nov; 289():114451. PubMed ID: 34673355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of the Private Sector in the COVID-19 Pandemic: Experiences From Four Health Systems.
    Wallace LJ; Agyepong I; Baral S; Barua D; Das M; Huque R; Joshi D; Mbachu C; Naznin B; Nonvignon J; Ofosu A; Onwujekwe O; Sharma S; Quayyum Z; Ensor T; Elsey H
    Front Public Health; 2022; 10():878225. PubMed ID: 35712320
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.